Bleichroeder Acquisition Corp. I to merge with Merlin Labs in $800M SPAC deal

Merlin, Inc.

Deal valued at $800M; expected close in Q1 2026 subject to shareholder and regulatory approvals.
SPAC will redomesticate to Delaware and rename to 'Merlin Labs, Inc.' upon closing.
Consideration payable in shares of new common stock; pre-funded notes and warrants converted separately.
Post-closing board to have up to 7 members; 2 appointed by SPAC CEO, remainder by Merlin Labs.

item 1.01 item 3.02 item 8.01 item 7.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.